Intravenous immune globulin in hereditary inclusion body myopathy: A pilot study

BMC Neurology

Volumn 7, Issue , 2007, Pages

  Sparks, Susan ^a,b   Rakocevic, Goran ^c   Joe, Galen ^d   Manoli, Irini ^a   Shrader, Joseph ^d   Harris Love, Michael ^d,e   Sonies, Barbara ^f   Ciccone, Carla ^a   Dorward, Heidi ^a   Krasnewich, Donna ^a   Huizing, Marjan ^a   Dalakas, Marinos C ^c   Gahl, William A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; BARIUM; DIPHENHYDRAMINE; GLYCOPROTEIN; IMMUNOGLOBULIN; N ACETYLGLUCOSAMINE; NAPROXEN; NERVE CELL ADHESION MOLECULE; ONDANSETRON; PARACETAMOL; SIALIC ACID;

ADULT; ANOREXIA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BARIUM MEAL; CASE REPORT; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INDUCED HEADACHE; ESOPHAGUS MOTILITY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEREDITARY INCLUSION BODY MYOPATHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLUENZA; LOADING DRUG DOSE; MALE; MUSCLE BIOPSY; MUSCLE STRENGTH; NAUSEA; PILOT STUDY; PROTEIN BLOOD LEVEL; QUADRICEPS FEMORIS MUSCLE; REPEATED DRUG DOSE; SHOULDER; SIALYLATION; SIDE EFFECT; TREATMENT OUTCOME; URINARY TRACT INFECTION; VOMITING;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOSITIS, INCLUSION BODY; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 33846946820     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-7-3     Document Type: Article

References (52)

1. Griggs RC Askanas V DiMaur S Engel A Karpati G Mendell JR Rowland LP Inclusion body myositis and myopathies Ann Neurol 1995 38 705-715 10.1002/ana.410380504 748686
2. Sadeh M Gadoth N Hadar H Ben-David E Vacuolar myopathy sparing the quadriceps Brain 1993 116 217-232 10.1093/brain/116.1.217 8453459
3. Sivakuma K Dalakas MC The spectrum of familial inclusion body myopathies in 13 families and description of a quadriceps sparing phenotype in non Iranian Jews Neurology 1996 47 977-984 8857730
4. Argov Z Eisenberg I Grabov-Nardini G Sadeh M Wirguin I Soffer D Mitrani-Rosenbaum S Hereditary inclusion body myopathy. The Middle Eastern genetic cluster Neurology 2003 60 1519-1523 12743242
5. Eisenberg I Avidan N Potikha T Hochner H Chen M Olender T Barash M Shemesh M Sadeh M Grabov-Nardini G Shmilevich I Friedmann A Karpati Bradley WG Baumbach L Lancet D Asher EB Beckmann JS Argov Z Mitrani-Rosenbaum S The UDP-N-acetylglucosamine 2-epimerase/ N-acetylmannosamine kinase gene is mutated in hereditary inclusion body myopathy Nat Genet 2001 29 83-89 10.1038/ng718 11528398
6. Hinderlich S Stasche R Zeitler R Reutter W A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase J Biol Chem 1997 272 24313-24318 10.1074/jbc.272.39.24313 9305887
7. Keppler OT Hinderlich S Langner J Schwartz-Albiez R Reutter W UDP-GlcNAc 2-epimerase: A regulator of cell surface sialylation Science 1999 284 1372-1376 10.1126/science.284.5418.1372 10334995
8. Darvish D Vahedifar P Huo Y Four novel mutations associated with autosomal recessive inclusion body myopathy (MIM: 600737) Mol Genet Metab 2002 77 252-256 10.1016/S1096-7192(02)00141-5 12409274
9. Vasconcelos OM Raghavan R Dalakas C GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM Neurology 2002 59 1776-1779 12473769
10. Del Bo R Baron P Prelle A Serafini M Moggio M Fonzo AD Castagni M Bresolin N Comi GP Novel missense mutation and large deletion of GNE gene in autosomal-recessive inclusion-body myopathy Muscle Nerve 2003 28 113-117 10.1002/mus.10391 12811782
11. Eisenberg I Grabov-Nardini G Hochner H Korner M Sadeh M Bertorini T Bushby K Castellan C Felice K Mendell J Merlini L Shilling C Wirguin I Argov Z Mitrani-Rosenbaum S Mutations spectrum of GNE in hereditary inclusion body myopathy sparing the quadriceps Hum Mutat 2003 21 99 10.1002/humu.9100 12497639
12. Broccolini A Ricci E Cassandrini D Gliubizzi C Bruno C Tonoli E Silvestri G Pescatori M Rodolico C Sinicropi S Servidei S Zara F Minetti C Tonali PA Mirabella M Novel GNE mutations in Italian families with autosomal recessive hereditary inclusion-body myopathy Hum Mutat 2004 23 632 10.1002/humu.9252 15146476
13. Kayashima T Matsuo H Satoh A Ohta T Yoshiura K Matsumoto N Nakane Y Niikawa N Kishino T Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene (GNE) J Hum Genet 2002 47 77-79 10.1007/s100380200004 11916006
14. Nishino I Noguchi S Murayama K Driss A Sugie K Oya Y Nagata T Chida K Takahashi T Takusa Y Ohi T Nishimiya J Sunohara N Ciafaloni E Kawai M Aoki M Nonaka I Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy Neurology 2002 59 1689-1693 12473753
15. Tomimitsu H Ishikawa K Shimizu J Ohkoshi N Kanazawa I Mizusawa H Distal myopathy with rimmed vacuoles: Novel mutations in the GNE gene Neurology 2002 59 451-454 12177386
16. Sparks SE Ciccone C Lalor M Orvisky E Klootwijk R Savelkoul PJ Dalakas MC Krasnewich DM Gahl WA Huizing M Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human Hereditary Inclusion Body Myopathy Glycobiology 2005 15 1102-1110 10.1093/glycob/cwi100 15987957
17. Noguchi S Keira Y Murayama K Ogawa M Fujita M Kawahara G Oya Y Imazawa M Goto Y Hayashi YK Nonaka I Nishino I Reduction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles J Biol Chem 2004 279 11402-11407 10.1074/jbc.M313171200 14707127
18. Varki A Diversity in the sialic acids Glycobiology 1992 2 25-40 10.1093/ glycob/2.1.25 1550987
19. Varki A Sialic acids as ligands in recognition phenomena FASEB J 1997 11 248-255 9068613
20. Kelm S Schauer R Sialic acids in molecular and cellular interactions Int Rev Cytol 1997 175 137-240 9203358
21. Saito F Tomimitsu H Aria K Nakai S Kanda T Shimizu T Mizusawa H Matsumura K A Japanese patient with distal myopathy with rimmed vacuoles: Missense mutations in the epimerase domaine of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene accompanied by hyposialiylation of skeletal muscle glycoproteins Neuromusc Disord 2004 14 158-161 10.1016/j.nmd.2003.09.006 14733963
22. Tajima Y Uyama E Go S Sato C Tao N Kotani M Hino H Suzuki A Sanai Y Kitajima K Sakuraba H Distal Myopathy with Rimmed Vacuoles: Impaired O-glycan formation in muscular glycoproteins Am J Pathol 2005 166 1121-1130 15793292
23. Ricci E Broccolini A Gidaro T Morosetti R Gliubizzi C Frusciante R Di Lella GM Tonali PA Mirabella M NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutations Neurology 2006 66 755-758 10.1212/01.wnl.0000200956.76449.3f 16534119
24. Huizing M Rakocevic G Sparks SE Mamali I Shatunov A Goldfarb L Krasnewich D Gahl WA Dalakas MC Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations Mol Genet Metab 2004 81 196-202 10.1016/j.ymgme.2003.11.012 14972325
25. Michele DE Campbell KP Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function J Biol Chem 2003 278 15457-15460 10.1074/jbc.R200031200 12556455
26. Martin PT Dystroglycan glycosylation and its role in matrix binding in skeletal muscle Glycobiology 2003 13 55R-66R 10.1093/glycob/cwg076 12736199
27. Grewal PK Hewitt JE Glycosylation defects: A new mechanism for muscular dystrophy? Hum Mol Genet 2003 12 Spec No 2 R259-R264 10.1093/hmg/ddg272 12925572
28. Winder SJ The complexities of dystroglycan Trends Biochem Sci 2001 26 118-124 10.1016/S0968-0004(00)01731-X 11166570
29. Endo T Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies Acta Myol 2005 24 64-69 16550917
30. Sydow O Sialic acid content in serum IgG from patients with myotonic dystrophy compared to healthy controls Acta Neurol Scand 1989 80 476-478 2511731
31. Andres PL Hedlund W Finison L Conlon T Felmus M Munsat TL Quantitative motor assessment in amyotrophic lateral sclerosis Neurology 1986 36 937-941 3714055
32. Robbins J Levine R Wood J Roecker EB Luschei E Age effects on lingual pressure generation as a risk factor for dysphagia J Gerontol A Biol Sci Med Sci 1995 50 M257-262 7671027
33. Robbins J Gangnon RE Theis SM Kays SA Hewitt AL Hind JA The effects of lingual exercise on swallowing in older adults J Am Geriatr Soc 2005 53 1483-1489 10.1111/j.1532-5415.2005.53467.x 16137276
34. Lin M-R Hwang H-F Hu M-H Wu H-DI Wang Y-W Huang F-C Psychometric comparisons of the timed up and go, one-leg stand, functional reach, and tinetti balance measures in community-dwelling older people J Am Geriatr Soc 2004 52 1343-1348 10.1111/j.1532-5415.2004.52366.x 15271124
35. ATS statement Guidelines for the six-minute walk test Am J Respir Crit Care Med 2002 166 111-117 12091180
36. van Eijk HG van Noort WL The analysis of human serum transferrins with the PhastSystem: Quantitation of microheterogeneity Electrophoresis 1992 13 354-358 10.1002/elps.1150130173 1505496
37. Savelkoul PJM Manoli I Sparks S Ciccone C Gahl WA Krasnewich DM Huizing M Normal sialylation status of N-linked and O-GalNAc linked glycans in Hereditary Inclusion Body Myopathy Mol Genet Metab 2006 88 389-390 10.1016/j.ymgme.2006.04.011 16762577
38. Wopereis S Grunewald S Monrova E Penzien JM Briones P Garcia-Silva MT Demacker PN Huijben KM Wevers RA Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis Clin Chem 2003 49 1839-1845 10.1373/clinchem.2003.022541 14578315
39. Ronn LC Berezin V Bock E The neural cell adhesion molecule in synaptic plasticity and ageing Int J Dev Neurosci 2000 18 193-199 10.1016/ S0736-5748(99)00088-X 10715574
40. Illa I Leon-Monzon M Dalakas MC Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells Ann Neurol 1992 31 46-52 10.1002/ana.410310109 1371910
41. Franz CK Rutishauser U Rafuse VF Polysialylated neural cell adhesion molecule is necessary for selective targeting of regenerating motor neurons J Neurosci 2005 25 2081-2091 10.1523/JNEUROSCI.4880-04.2005 15728848
42. Covault J Sanes JR Neural Cell Adhesion Molecule (N-CAM) accumulates in denervated and paralyzed skeletal muscles Proc Natl Acad Sci USA 1985 82 4544-4548 391139 3892537 10.1073/pnas.82.13.4544
43. Hinderlich S Salama I Eisenberg I Potikha T Mantey LR Yarema KJ Horstkorte R Argov Z Sadeh M Reutter W Mitrani-Rosenbaum S The homozygous M712T mutation of UDP-N-acetylglucosamine 2-epimerase/ N-acetylmannosamine kinase results in reduced enzyme activities but not in altered overall cellular sialylation in hereditary inclusion body myopathy FEBS Lett 2004 566 105-109 10.1016/j.febslet.2004.04.013 15147877
44. Salama I Hinderlich S Shlomai Z Eisenberg I Krause S Yarema K Argov Z Lochmuller H Reutter W Dabby R Sadeh M Ben-Bassat H Mitrani-Rosenbaum S No overall hyposialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutation Biochem Biophy Res Comm 2005 328 221-226 10.1016/j.bbrc.2004.12.157
45. Broccolini A Gliubizzi C Pavoni E Gidaro T Morosetti R Sciandra F Giardina B Tonali P Ricci E Brancaccio A Mirabella M α-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy Neuromusc Disord 2005 15 177-184 10.1016/j.nmd.2004.10.001 15694140
46. Seppala R Renlund M Bernardini I Tietze F Gahl WA Renal handling of free sialic acid in normal humans and patients with Salla disease, renal Fanconi syndrome, or glomerular insufficiency Lab Invest 1990 63 197-203 2381164
47. Kaneko Y Nimmerjahn F Ravetch JV Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation Science 2006 313 670-673 10.1126/science.1129594 16888140
48. Dalakas MC Intravenous immunoglobulin I auoimmune neuromuscular diseases JAMA 2004 291 2367-2375 10.1001/jama.291.19.2367 15150209
49. Aitkens S Lord J Bernauer E Fowler WM Lieberman JS Berck P Relationship of manual muscle testing to objective strength measurements Muscle Nerve 1989 12 173-177 10.1002/mus.880120302 2725546
50. Hinderlich S Nohring S Weise C Franke P Stasche R Reutter W Purification and characterization of N-acetylglucosamine kinase from rat liver-comparison with UDP-N-acetylglucosamine 2-epimerase/ N-acetylmannosamine kinase Eur J Biochem 1998 252 133-139 10.1046/ j.1432-1327.1998.2520133.x 9523722
51. Schwarzkopf M Knobelock KP Rohde E Hinderlich S Wiechens N Lucka L Horak I Reutter W Horstkorte R Sialylation is essential for early development in mice Proc Natl Acad Sci USA 2002 99 5267-5270 122758 11929971 10.1073/ pnas.072066199
52. Huizing M Kloowijk R Galeano B Manoli I Sun MS Ciccone C Darvish D Krasnewich D Gahl WA N-Acetylmannosamine treatment rescues a mouse model of Hereditary Inclusion Body Myopathy Glycobiology 2006 16 1110 (Abstr. 35)